Geode Capital Management LLC Has $592.98 Million Stock Position in STERIS plc $STE

Geode Capital Management LLC boosted its holdings in shares of STERIS plc (NYSE:STE) by 1.9% in the second quarter, HoldingsChannel reports. The fund owned 2,479,108 shares of the medical equipment provider’s stock after buying an additional 46,859 shares during the quarter. Geode Capital Management LLC’s holdings in STERIS were worth $592,980,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Vanguard Group Inc. boosted its holdings in shares of STERIS by 0.4% during the first quarter. Vanguard Group Inc. now owns 11,957,852 shares of the medical equipment provider’s stock worth $2,710,247,000 after purchasing an additional 46,628 shares during the period. Generation Investment Management LLP increased its stake in STERIS by 5.4% in the 1st quarter. Generation Investment Management LLP now owns 3,354,545 shares of the medical equipment provider’s stock valued at $760,308,000 after buying an additional 170,392 shares during the period. Orbis Allan Gray Ltd purchased a new stake in STERIS in the 1st quarter worth approximately $349,950,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in shares of STERIS by 55.2% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,520,479 shares of the medical equipment provider’s stock valued at $344,617,000 after buying an additional 540,999 shares during the period. Finally, Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in shares of STERIS by 3.9% in the second quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,346,039 shares of the medical equipment provider’s stock worth $323,345,000 after acquiring an additional 50,764 shares during the last quarter. Institutional investors and hedge funds own 94.69% of the company’s stock.

STERIS Trading Down 0.6%

Shares of STE stock opened at $258.75 on Friday. STERIS plc has a 12 month low of $200.98 and a 12 month high of $268.30. The company has a market cap of $25.40 billion, a PE ratio of 39.62 and a beta of 1.02. The company has a quick ratio of 1.53, a current ratio of 2.22 and a debt-to-equity ratio of 0.27. The business’s 50 day moving average is $245.98 and its two-hundred day moving average is $240.23.

STERIS (NYSE:STE) last posted its quarterly earnings data on Wednesday, November 5th. The medical equipment provider reported $2.47 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.38 by $0.09. The business had revenue of $1.46 billion during the quarter, compared to the consensus estimate of $1.43 billion. STERIS had a net margin of 11.61% and a return on equity of 14.17%. During the same period in the prior year, the firm earned $2.14 EPS. STERIS has set its FY 2026 guidance at 10.150-10.30 EPS. Equities analysts predict that STERIS plc will post 9.08 EPS for the current year.

STERIS Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 18th. Investors of record on Tuesday, November 18th will be given a dividend of $0.63 per share. This represents a $2.52 annualized dividend and a dividend yield of 1.0%. The ex-dividend date of this dividend is Tuesday, November 18th. STERIS’s payout ratio is currently 36.21%.

Insider Buying and Selling

In other news, VP Renato Tamaro sold 3,204 shares of the company’s stock in a transaction that occurred on Wednesday, August 20th. The stock was sold at an average price of $249.24, for a total transaction of $798,564.96. Following the completion of the transaction, the vice president directly owned 7,221 shares in the company, valued at $1,799,762.04. The trade was a 30.73% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP John Adam Zangerle sold 15,000 shares of the firm’s stock in a transaction on Tuesday, November 11th. The stock was sold at an average price of $265.14, for a total transaction of $3,977,100.00. Following the completion of the sale, the vice president owned 33,669 shares in the company, valued at approximately $8,926,998.66. The trade was a 30.82% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 18,363 shares of company stock valued at $4,814,114. Insiders own 1.07% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on STE shares. Weiss Ratings reaffirmed a “buy (b)” rating on shares of STERIS in a research report on Tuesday, October 14th. KeyCorp raised their price objective on shares of STERIS from $277.00 to $288.00 and gave the company an “overweight” rating in a research report on Tuesday, July 22nd. Wall Street Zen raised shares of STERIS from a “buy” rating to a “strong-buy” rating in a research report on Sunday, September 14th. Finally, Morgan Stanley increased their price target on shares of STERIS from $276.00 to $295.00 and gave the stock an “overweight” rating in a research note on Friday, August 8th. Seven investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, STERIS presently has an average rating of “Moderate Buy” and an average price target of $273.50.

STERIS Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.